On January 5, 2022 Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, reported its participation in upcoming investor and healthcare conferences to be held in January 2022 (Press release, Genprex, JAN 5, 2022, https://www.genprex.com/news/genprex-to-participate-in-january-investor-and-healthcare-conferences-to-highlight-companys-gene-therapies-in-cancer-and-diabetes/ [SID1234598219]). Genprex’s President and Chief Executive Officer, Rodney Varner, and the Company’s Chief Medical Officer, Mark Berger, MD will lead the Company’s presentations.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Details on Genprex’s participation in January conferences include:
Event: HC Wainwright BIOCONNECT 2022 Virtual Conference
Conference Dates: January 10-13, 2022
Presentation Time: Available on-demand beginning January 10 at 7 a.m. EST
Presenters: Rodney Varner, President and Chief Executive Officer and Mark Berger, MD, Chief Medical Officer
Conference Registration: https://bit.ly/3lMBq6G
Webcast Link: https://bit.ly/3q5EewX
Event: Biotech Showcase 2022
Conference Dates: January 10-13, 2022
Presentation Time: Available on-demand beginning January 10
Presenter: Rodney Varner, President and Chief Executive Officer
Conference Registration: https://bit.ly/3y80EB5
Event: Precision: Lung Cancer World R&D Virtual Summit
Conference Dates: January 25-26
Presentation Date: Tuesday, January 25
Presenters: Mark Berger, MD, Chief Medical Officer
Conference Registration: https://bit.ly/3pxW1wg
Event: CEO Roadshow
Presentation Date: Wednesday, January 26
Presentation Time: 11 a.m. EST
Presenters: Rodney Varner, President and Chief Executive Officer
Location: Virtual Webinar
Conference Registration: https://bit.ly/3IxMrSY
At these virtual events, Mr. Varner and Dr. Berger will either be available to participate in virtual one-on-one meetings with registered participants or will be available for questions following the Company presentation. If available, a recording of these presentations will be available for replay on Genprex’s website for a period of time.